Integra LifeSciences Holdings (IART)
| Sector: | Health Care |
| |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 859 |
| % of all portfolios: | 0% |
| |
| History |
Portfolio Manager |
Activity ▲ |
Share change |
% change to portfolio |
| Q1 2026 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Sell 100.00% |
123,000 |
0.31 |
| Q4 2025 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Reduce 11.51% |
16,000 |
0.04 |
| Q1 2025 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Reduce 26.32% |
35,000 |
0.14 |
| Q4 2024 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Reduce 14.19% |
22,000 |
0.09 |
| Q2 2024 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
9,419 |
0.01 |
| Q3 2023 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 26.02% |
2,627 |
0.00 |
| Q2 2023 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 0.60% |
61 |
0.00 |
| Q1 2023 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Reduce 2.17% |
1,000 |
0.01 |
| Q1 2022 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Reduce 6.67% |
3,000 |
0.02 |
| Q4 2021 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
7,007 |
0.01 |
| Q3 2021 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 68.58% |
15,292 |
0.02 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Reduce 10.87% |
5,000 |
0.04 |
| Q1 2021 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 24.83% |
3,254 |
0.00 |
| Q4 2020 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 37.27% |
7,786 |
0.01 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.